Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Volume 19 Issue 4, April 2022
PP. 385-564
|
11 articles
Review | Open Access
N6-methyladenosine (m6A) RNA modification in tumor immunity
Published: 15 April 2022
2022, 19(4): 385-397
Review | Open Access
Methods for monitoring cancer cell pyroptosis
Published: 01 April 2022
2022, 19(4): 398-414
Review | Open Access
Research progress in hepatitis B virus covalently closed circular DNA
Published: 01 April 2022
2022, 19(4): 415-431
Review | Open Access
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Published: 01 April 2022
2022, 19(4): 432-449
Review | Open Access
Breast cancer screening and early diagnosis in Chinese women
Published: 01 April 2022
2022, 19(4): 450-467
Original Article | Open Access
SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer
Published: 01 April 2022
2022, 19(4): 468-485
Original Article | Open Access
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
Published: 01 April 2022
2022, 19(4): 486-503
Original Article | Open Access
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Published: 01 April 2022
2022, 19(4): 504-517
Original Article | Open Access
Is adjuvant chemotherapy necessary for early gastric cancer?
Published: 01 April 2022
2022, 19(4): 518-532
Original Article | Open Access
Comparative profiling of immune genes improves the prognoses of lower grade gliomas
Published: 01 April 2022
2022, 19(4): 533-550
Original Article | Open Access
Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
Published: 01 April 2022
2022, 19(4): 551-564